IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 1258.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 22-Feb-2017
Cell Reports
Scientists identify chain reaction that shields breast cancer stem cells from chemotherapy
Working with human breast cancer cells and mice, researchers at Johns Hopkins say they have identified a biochemical pathway that triggers the regrowth of breast cancer stem cells after chemotherapy.
US Department of Defense, American Cancer Society

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine

Public Release: 21-Feb-2017
The Lancet
One-off bowel scope cuts cancer risk for at least 17 years
A one-off bowel screening test reduces the risk of developing bowel cancer by more than one-third and could save thousands of lives.
Medical Research Council, National Institute for Health Research, Cancer Research UK

Contact: Fiona Dennehy
fiona.dennehy@cancer.org.uk
020-346-96770
Cancer Research UK

Public Release: 21-Feb-2017
PLOS ONE
Israeli, Palestinian researchers cooperate to find risks for B cell non-hodgkin lymphoma
Most epidemiological studies of Non-Hodgkin's Lymphoma (NHL) have been carried out in North American and European populations, with very few focusing on B-cell NHL in Middle Eastern populations. Now, Israeli and Palestinian researchers have conducted a large scale epidemiological study examining risk factors for B-NHL and its sub-types in the Israeli and Palestinian populations, finding some risk factors common to both groups, and some that are unique to only one population.
MERC/USAID, Israel Science Foundation, Hadassah University Hospital Compensatory Fund

Contact: Dov Smith
dovs@savion.huji.ac.il
972-258-82844
The Hebrew University of Jerusalem

Public Release: 21-Feb-2017
Annals of Oncology
Death rates from cancer will fall faster in men than in women in Europe in 2017
Death rates from cancer in the European Union (EU) are falling faster in men than in women, according to the latest predictions for European cancer deaths in 2017, published in the leading cancer journal Annals of Oncology. Compared with 2012, death rates in men will fall by just over eight percent to 132 per 100,000 of the population in 2017, while in women the decline will be around four percent to 84.5 per 100,000.
Italian Association for Cancer Research, MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca), SIR (Scientific Independence of Young Researchers) 2014 grant, the European Cooperation in Science and Technology--COST Action BM1204 EU-Pancreas

Contact: Emma Mason
wordmason@mac.com
European Society for Medical Oncology

Public Release: 21-Feb-2017
Cancer Epidemiology, Biomarkers & Prevention
Hispanic cancer mortality varies among ethnic groups
Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major Hispanic ethnic groups.
NIH/National Institute of General Medical Sciences

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research

Public Release: 21-Feb-2017
Canadian Medical Association Journal
Exercise most important lifestyle change to help reduce risk of breast cancer recurrence
For patients with breast cancer, physical activity and avoiding weight gain are the most important lifestyle choices that can reduce the risk of cancer recurrence and death, according to an evidence-based review published in CMAJ.

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
800-267-9703
Canadian Medical Association Journal

Public Release: 21-Feb-2017
Radiology
Screening MRI benefits women at average risk of breast cancer
MRI screening improves early diagnosis of breast cancer in all women-not only those at high risk-according to a new study from Germany.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 21-Feb-2017
Radiology
Novel breast tomosynthesis technique reduces screening recall rate
A new digital breast tomosynthesis technique has the potential to reduce the rate at which women are called back for additional examinations without sacrificing cancer detection, according to a new study.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 21-Feb-2017
Oncogene
The way breast cancer genes act could predict your treatment
A Michigan State University breast cancer researcher has shown that effective treatment options can be predicted based on the way certain breast cancer genes act or express themselves.
National Institutes of Health, Susan G. Komen Foundation

Contact: Sarina Gleason
sarina.gleason@cabs.msu.edu
517-355-9742
Michigan State University

Public Release: 21-Feb-2017
Nature Communications
Danish discovery opens up for new type of immunological treatment of cancer
Researchers from Aarhus University have found an important piece of the puzzle leading towards an understanding of how our innate immune system reacts against viral infections and recognises foreign DNA, for example from dying cancer cells. The discovery may prove to be of great importance for immunological treatment of cancer as well as autoimmune diseases in the future.
The Lundbeck Foundation, Danish Council for Independent Research, Augustinus Foundation, Frode V. Nyegaard og Hustrus Foundation

Contact: Martin Roelsgaard Jakobsen
mrj@biomed.au.dk
45-87-16-78-46
Aarhus University

Public Release: 21-Feb-2017
Molecular Therapy - Oncolytics
Using a rabbit virus to treat multiple myeloma
Treating multiple myeloma (MM) with myxoma virus (MYXV) eliminated a majority of malignant cells in preclinical studies, report investigators at the Medical University of South Carolina (MUSC) and elsewhere in an article published online on Dec. 7, 2016 by Molecular Therapy -- Oncolytics. Furthermore, introduction of MYXV had no impact on the bone marrow compartment and elicited a strong immune response that eradicated disease in some animals.
NIH/National Institute of Allergy and Infectious Diseases,NIH/National Cancer Institute, American Cancer Society, Hollings Cancer Center's Cancer Center, South Carolina Clinical and Translational Research Institute

Contact: Heather Woolwine
woolwinh@musc.edu
843-792-7669
Medical University of South Carolina

Public Release: 21-Feb-2017
International Journal of Radiation Oncology, Biology, Physics
Penn expert calls for shorter radiation use in prostate cancer treatment
Men with prostate cancer can receive shorter courses of radiation therapy than what is currently considered standard, according to Justin Bekelman, M.D., an associate professor of Radiation Oncology, Medical Ethics, and Health Policy at the University of Pennsylvania's Perelman School of Medicine and Abramson Cancer Center.
NIH/National Cancer Institute

Contact: John Infanti
john.infanti@uphs.upenn.edu
215-301-5221
University of Pennsylvania School of Medicine

Public Release: 21-Feb-2017
Journal of Clinical Oncology
Hormonal maintenance therapy may improve survival in women with chemo-resistant rare ovarian or peri
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance therapy (HMT) may significantly improve survival, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center

Public Release: 21-Feb-2017
ASCO-Society for Immunotherapy in Cancer
Gut bacteria associated with cancer immunotherapy response in melanoma
Melanoma patients' response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, researchers at The University of Texas MD Anderson Cancer Center report at the ASCO-Society for Immunotherapy in Cancer meeting in Orlando.

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center

Public Release: 21-Feb-2017
British Journal of Nutrition
Unlocking the heart-protective benefits of soy
A product of digesting a micronutrient found in soy may hold the key to why some people seem to derive a heart-protective benefit from eating soy foods, while others do not. Japanese men who are able to produce equol -- a substance made by some types of "good" gut bacteria when they metabolize isoflavones (micronutrients found in dietary soy) -- have lower levels of a risk factor for heart disease than their counterparts who cannot produce it.
National Institutes of Health, Japanese Ministry of Education, Culture, Sports, Science and Technology, Pitt Public Health's Department of Epidemiology

Contact: Allison Hydzik
HydzikAM@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 21-Feb-2017
American Journal of Preventive Medicine
E-cigarettes popular among smokers with existing illnesses
In the US more than 16 million people with smoking-related illnesses continue to use cigarettes. According to a new study in the American Journal of Preventive Medicine, current and former smokers who suffer from disease are more likely to have reported using an e-cigarette, meaning these patients may see e-cigarettes as safer or less harmful than combustible cigarettes and a way to reduce the risks posed by traditional smoking.
National Institute on Drug Abuse, NIH/National Heart Lung and Blood Institute

Contact: Jillian B. Morgan
ajpmmedia@elsevier.com
734-936-1590
Elsevier Health Sciences

Public Release: 21-Feb-2017
Nature Communications
Discovery of a new gene critical in the development of lung and pancreatic cancers
Researchers at the Center for Applied Medical Research (CIMA) of the University of Navarra (Spain) have identified a critical gene, FOSL1, in the development of lung and pancreatic cancer. The work, published in Nature Communications, shows that the inhibition of FOSL1 brings about a great reduction in the size of the tumors in the lungs and pancreas. Thus, the results present this gene as a new molecular target to which new drugs should be directed.

Contact: Miriam Salcedo
miriamsalcedo@unav.es
34-948-194-700
Universidad de Navarra

Public Release: 21-Feb-2017
Cancer Research
Prostate cancer cells grow with malfunction of cholesterol control in cells
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem. Now a team led by researchers at the Duke Cancer Institute have identified a cellular process that cancer cells hijack to hoard cholesterol and fuel their growth. Identifying this process could inform the development of better ways to control cholesterol accumulation in tumors, potentially leading to improved survival for prostate cancer patients.
National Institutes of Health, Stewart Rahr Prostate Cancer Foundation Young Investigator Award, Department of Defense

Contact: Sarah Avery
sarahaver@gmail.com
919-660-1306
Duke University Medical Center

Public Release: 21-Feb-2017
Proceedings of the National Academy of Sciences
Penn/Wistar study finds 'sweet spot' where tissue stiffness drives cancer's spread
Researchers from the University of Pennsylvania and The Wistar Institute have now found that physical forces exerted between cancer cells and the ECM are enough to drive a shape change necessary for metastasis. Those forces converge on an optimal stiffness that allows cancer cells to spread.
NIH/National Cancer Institute, National Institutes of Health, National Science Foundation

Contact: Evan Lerner
elerner@upenn.edu
215-573-6604
University of Pennsylvania

Public Release: 20-Feb-2017
Proceedings of the National Academy of Sciences
Pitt study finds potential marker of drug response in many cancer types
Researchers at the University of Pittsburgh School of Medicine have uncovered a novel genetic mechanism of thyroid cancer, as well as a marker that may predict response to a particular class of drugs, not just in patients with thyroid cancer, but in those with many other types of cancer as well.
National Institutes of Health, David and Nancy Brent

Contact: Allison Hydzik
HydzikAM@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 20-Feb-2017
Leukemia
Metabolism drives growth and division of cancer cells
Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism. This process, termed 'Warburg Effect,' was neglected until recently by cancer research, but latest results show ist fundamental importance for the development of aggressive tumors. Richard Moriggl from the VetmeduniVienna now published in Leukemia how the tumor promoter STAT5 integrates metabolic signals that contribute to oncogenic transformation and may have thus identified a new target to tackle cancer.

Contact: Richard Moriggl
richard.moriggl@vetmeduni.ac.at
43-125-077-5622
University of Veterinary Medicine -- Vienna

Public Release: 20-Feb-2017
Journal of Materials Science
New approach for the capture of tumor-derived exosomes from a prostate cancer cell line
In a new paper in Springer's Journal of Materials Science, researchers at Washington State University report a new approach for the effective capture of tumor-derived exosomes from a prostate cancer cell line. Exosomes are small secreted vesicles that play a key role in intercellular communication and cancer progression.
Prostate Cancer Research Program

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer

Public Release: 20-Feb-2017
Proceedings of the National Academy of Sciences
Protein once thought exclusive to neurons helps some cancers grow, spread, defy death
How we think and fall in love are controlled by lightning-fast electrochemical signals across synapses, the dynamic spaces between nerve cells. Until now, nobody knew that cancer cells can repurpose tools of neuronal communication to fuel aggressive tumor growth and spread.

Contact: Deborah Wormser
deborah.wormser@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

Public Release: 20-Feb-2017
Scientific Reports
Biomarker predicts poor prognosis in African-Americans with triple-negative breast cancer
Having high levels of a certain biomarker is linked to poor prognosis in African-American patients with triple-negative breast cancer, while the same biomarker doesn't influence disease outcomes in white patients, according to a new study.
NIH/National Cancer Institute, NIH/National Institute on Minority Health and Health Disparities

Contact: LaTina Emerson
lemerson1@gsu.edu
404-413-1353
Georgia State University

Public Release: 20-Feb-2017
Journal of Global Oncology
New approach to cervical cancer care in Botswana cuts treatment lag time in half
Cervical cancer is the leading cause of cancer deaths for women low- and middle-income countries, including Botswana, where 75 percent of cervical cancer patients suffer from advanced forms of the disease. These patients can face wait times as long as five months after diagnosis before receiving lifesaving treatment. A new, multidisciplinary model of cervical cancer care developed by a University of Pennsylvania team based in Botswana cut the delay between diagnosis and treatment by more than 50 percent.

Contact: Johanna Harvey
johanna.harvey@uphs.upenn.edu
215-349-8062
University of Pennsylvania School of Medicine

Showing releases 1-25 out of 1258.

1 | 2 | 3 | 4 | 5 > >>

  Search News Releases

     

 

EurekAlert!